

By empowering talented scientists that intensely focus on cardiovascular and metabolic product development and working hand-in-hand with clients to develop the most relevant forward-looking resources possible, we achieve new standards of analytical excellence and deliver the most accurate, insightful, and robust market planning resources available.
Through rigorous and sophisticated methodologies, our firm interprets numerous scientific, clinical, and therapy area developments on an ongoing basis and is adept at evaluating the commercial impact of complicated interconnected market events and how changes in treatment trends, patient populations, and risk factors will weigh into the future marketplace. Our fundamental belief is that clients are best served by our team’s full-time, exclusive study of cardio-metabolic markets which enable the production of market planning resources that contain more depth, insight, and precision than would otherwise be possible.
CVrg’s express purpose is to help our clients succeed in creating winning strategies and making the right business decisions for their new products, brands, franchises, partnerships, and alliances.
Our analysts become experts through interactions with Key Opinion Leaders, scientists, and researchers,
as well as year-round surveillance of:
• Medical conferences (e.g., ESC, ADA, ASN)
• News sources (e.g. Medscape, FiercePharma, Adis)
• Primary literature (e.g. NEJM, Lancet)
• Clinical trial databases (e.g. ClinicalTrials.gov, ClinicalTrials.jp, ClinicalTrialsRegister.eu, ISRCTN.com)
• Company communications (e.g. earnings calls, conference webcasts, press releases)


• 17 of the top 20 pharmaceutical companies by sales volume
• 9 of the top 10 metabolic disease pharmaceutical companies by sales volume
• Multiple small pharma companies
Geographically, we provide coverage to clients worldwide including: United States, United Kingdom, France, Germany, Denmark, Japan, China, India, Italy, Sweden, Switzerland, Spain, Brazil, Canada, and Russia.
By empowering talented scientists that intensely focus on cardiovascular and metabolic product development and working hand-in-hand with clients to develop the most relevant forward-looking resources possible, we achieve new standards of analytical excellence and deliver the most accurate, insightful, and robust market planning resources available.
Through rigorous and sophisticated methodologies, our firm interprets numerous scientific, clinical, and therapy area developments on an ongoing basis and is adept at evaluating the commercial impact of complicated interconnected market events and how changes in treatment trends, patient populations, and risk factors will weigh into the future marketplace. Our fundamental belief is that clients are best served by our team’s full-time, exclusive study of cardio-metabolic markets which enable the production of market planning resources that contain more depth, insight, and precision than would otherwise be possible.
CVrg’s express purpose is to help our clients succeed in creating winning strategies and making the right business decisions for their new products, brands, franchises, partnerships, and alliances.
Our analysts become experts through interactions with Key Opinion Leaders, scientists, and researchers,
as well as year-round surveillance of:
• Medical conferences (e.g., ESC, ADA, ASN)
• News sources (e.g. Medscape, FiercePharma, Adis)
• Primary literature (e.g. NEJM, Lancet)
• Clinical trial databases (e.g. ClinicalTrials.gov, ClinicalTrials.jp, ClinicalTrialsRegister.eu, ISRCTN.com)
• Company communications (e.g. earnings calls, conference webcasts, press releases)
• 17 of the top 20 pharmaceutical companies by sales volume
• 9 of the top 10 metabolic disease pharmaceutical companies by sales volume
• Multiple small pharma companies
Geographically, we provide coverage to clients worldwide including: United States, United Kingdom, France, Germany, Denmark, Japan, China, India, Italy, Sweden, Switzerland, Spain, Brazil, Canada, and Russia.